Infinity Pharmaceuticals Cash Beginning of Year Trend

Infinity Pharmaceuticals Inc -- USA Stock  

USD 2.56  0.02  0.79%

This module enables investors to look at Infinity Pharmaceuticals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Cost of Revenue of 32.5 M, Gross Profit of 18.7 M or Interest Expense of 1.6 M, but also many exotic indicators such as Long Term Debt to Equity of 0.2339, PPandE Turnover of 5.4358 or Receivables Turnover of 1 K. This module is a perfect complement to use when analyzing Infinity Pharmaceuticals Valuation or Volatility. It can also complement various Infinity Pharmaceuticals Technical models. Please also check analysis of Infinity Pharmaceuticals Correlation with competitors.
Showing smoothed Cash Beginning of Year of Infinity Pharmaceuticals Inc with missing and latest data points interpolated.
Cash Beginning of Year  10 Years Trend  
Slightly volatile
 Cash Beginning of Year 

Infinity Pharmaceuticals Cash Beginning of Year Over Time

2016-12-31  307,405,000 
2017-12-31  307,405,000 
2018-12-31  361,652,941 

Other Fundumenentals


Regression Statistics

Arithmetic Mean  136,666,107
Geometric Mean  74,388,809
Coefficient Of Variation  99.09
Mean Deviation  119,427,601
Median  74,147,479
Standard Deviation  135,424,221
Range  345,365,712
R Value  0.82
R Squared  0.66
Significance  0.00068307
Slope  28,350,282

Currently Trending

Sold over 70 shares of
a day ago ago
Traded for 37.94
Purchased over 40 shares of
a day ago ago
Traded for 61.5945
Sold over 200 shares of
a day ago ago
Traded for 11.15